Category: "status epilepticus"

Don’t Miss Tomorrow Night… Epilepsy Association “Zoom-Learn-Ask”

Don’t Miss Tomorrow Night… Epilepsy Association “Zoom-Learn-Ask”

Click on the link below to join https://us02web.zoom.us/j/88326176138?pwd=L0ZCNS9Cd2Jtakp2dDgyRmZxcXhwdz09  

Medical Musings: Epilepsy is a common neurological disorder

Medical Musings: Epilepsy is a common neurological disorder

A seizure attack occurs when there is an acute abnormality in the electrical activity in the brain. To be classified as an epileptic, a person must have experienced either a minimum of two seizures that are at least 24 hours apart and not incited by a known medical disorder or one seizure and a high […]

First Orally Delivered Diazepam Product for The Management of Seizure Clusters May Be Approved Soon

First Orally Delivered Diazepam Product for The Management of Seizure Clusters May Be Approved Soon

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant™ (diazepam) Buccal Film Prescription Drug User Fee Act (PDUFA) Target Goal Date set for December 23, 2021 If approved by the FDA for U.S. market access, Libervant would be the first orally delivered diazepam product for the management of seizure clusters Aquestive […]

Paramedic Treatment of Status Epilepticus Rarely Consistent With Guidelines

Paramedic Treatment of Status Epilepticus Rarely Consistent With Guidelines

Of more than 9,000 EMS encounters, only 3.9% followed expert recommendations Prehospital treatment of people with status epilepticus rarely was consistent with expert guidelines, an analysis of emergency medical service (EMS) agency records showed. Initial treatment was concordant with guidelines in only 3.9% of 9,176 EMS encounters for status epilepticus, reported Elan Guterman, MD, of […]

SciSparc to Commence a Pre-Clinical Study Using its SCI-210 Cannabidiol Based Treatment for Epilepsy

SciSparc to Commence a Pre-Clinical Study Using its SCI-210 Cannabidiol Based Treatment for Epilepsy

SciSparc Ltd. (formerly known as Therapix Biosciences Ltd.), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced it has entered an agreement with The Sheba Fund for Health Services and Research, to perform a pre-clinical study for the evaluation of the Company’s SCI-210 drug development program, a proprietary novel pharmaceutical preparation […]

Major epilepsy study offers much-needed answers on 3 lifesaving seizure drugs

Major epilepsy study offers much-needed answers on 3 lifesaving seizure drugs

Researchers urge doctors to increase dose of commonly used drug There are effective treatments to stop life-threatening epilepsy seizures when the initial treatment has failed, a sweeping new study reveals. The study offers important answers about three such emergency drugs that are used to treat prolonged seizures, known as status epilepticus, even though physicians have […]

RECENT NEWS